Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
The Anti-plgf Antibody (5d11d4) Specifically Reduces Choroidal Neovascularization in vivo on a Mouse Model — Sara Van de Veire (2010) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
The Anti-plgf Antibody (5d11d4) Specifically Reduces Choroidal Neovascularization in vivo on a Mouse Model
Shared by
Peter Carmeliet
Aarhus University
The Anti-plgf Antibody (5d11d4) Specifically Reduces Choroidal Neovascularization in vivo on a Mouse Model
Article
2010
en
Authors
+5 more
SV
Sara Van de Veire
TB
Tine Van Bergen
MM
Massimiliano Mazzone
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2008
Anti-PlGF (Placental Growth Factor) Reduces Choroidal Neovascularization in a Mouse Model of Age-Related Macular Degeneration (ARMD)
Sara Van de Veire
,
Stanley A. Vinores
,
Aleksandar Perić
,
Massimiliano Mazzone
,
G. Moons
,
J M Stassen
,
Agnès Noël
,
Ingeborg Stalmans
,
Peter Carmeliet
Article
2007
Placental growth factor (PlGF) inhibition reduces choroidal neovascularization in a mouse model for age‐related macular degeneration
Sara Van de Veire
,
G. Moons
,
SA Vinores
,
Peter Carmeliet
,
Ingeborg Stalmans
Article
2005
A monoclonal antibody against murine PlGF blocks primary tumor growth in syngeneic mouse tumor models
C Fischer
,
Mieke Dewerchin
,
Thien H. Ngo
,
Geert Reyns
,
A Scholz
,
JM Stassen
,
Hilde Depraetere
,
D Collen
,
Lieve Moons
,
Peter Carmeliet
Article
2007
The mechanism, efficacy and safety of anti-placental growth factor (PlGF) antibodies in CNV formation in a mouse model for ARMD
Sara Van de Veire
,
Stanley A. Vinores
,
Lieve Moons
,
Peter Carmeliet
,
Ingeborg Stalmans
Article
2005
Implication of the hypoxia response element of the vegf promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development
Stanley A. Vinores
,
Wei‐Hong Xiao
,
Sadia Aslam
,
Jikui Shen
,
Yuji Oshima
,
Hiroyuki Nambu
,
Hansheng Liu
,
Peter Carmeliet
,
Peter A. Campochiaro
Discussion(0)
No comments yet. Be the first to comment.